1Eastern Along Pharmaceutical, Foshan, Guangdong528234, China
2Huanan Agricultural University, Guangzhou510000, China
*Corresponding Author: Shuzhen Zhou, Eastern Along Pharmaceutical, Foshan, Guangdong, 528234, China, Email: zhousz@easternalong.com
Online published on 5 February, 2026.
The clinical treatment of dairy cow mastitis during the lactation period plays a significant role in dairy manufacture. In this work, 3 groups of lactating dairy cows with clinical mastitis were selected, for the first time, to explore the treatment effects using cefquinome sulfate and lincomycin hydrochloride through the udder injection.
The treatment effects with the udder injection of cefquinome sulfate and lincomycin hydrochloride were compared based on effective rate, cure rate, somatic cell reduction in the milk, decrease of cow body temperature and recovery of milk yield.
Both cefquinome sulfate and lincomycin hydrochloride showed effective treatment on the dairy cow mastitis during the lactation period. The effective rate and the cure rate obtained with cefquinome sulfate were 88% and 80%, which were higher than those treated with lincomycin hydrochloride (effective rate: 72% and cure rate: 64%). Furthermore, the cefquinome sulfate test group seemed to display a better role in the reduction of somatic cells in milk, a decrease of cow body temperature and the recovery of milk yield.
Cefquinome sulfate, Clinical study, Cow mastitis, Lactating cow, Lincomycin hydrochloride
